| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $218.71M | $7.00M | $23.39M | $50.93M | $27.94M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $378.02M | $333.98M | $157.81M | $113.43M | $78.21M |
| R&D | $314.70M | $294.67M | $129.51M | $89.54M | $58.16M |
| SG&A | $63.32M | $39.30M | $28.31M | $23.90M | $20.05M |
| Operating Income | -$159.31M | -$326.98M | -$134.43M | -$62.50M | -$50.27M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$113.70M | -$274.48M | -$112.96M | -$58.66M | -$49.76M |
| EPS (basic) | -1.2800 | -3.3600 | -1.9600 | -1.4200 | -1.4100 |
| EPS (diluted) | -1.2800 | -3.3600 | -1.9600 | -1.4200 | -1.4100 |
| Shares (diluted) | $88.49M | $81.68M | $57.52M | $41.44M | $35.25M |